Institutional shares held 68.8 Million
166K calls
31.3K puts
Total value of holdings $1.87B
$4.49M calls
$848K puts
Market Cap $1.46B
53,205,300 Shares Out.
Institutional ownership 129.31%
# of Institutions 221


Latest Institutional Activity in ARVN

Top Purchases

Q3 2024
Assenagon Asset Management S.A. Shares Held: 140K ($3.84M)
Q3 2024
Banque Pictet & Cie Sa Shares Held: 121K ($3.32M)
Q3 2024
Abrdn PLC Shares Held: 78.6K ($2.16M)
Q3 2024
China Universal Asset Management Co., Ltd. Shares Held: 13.2K ($363K)
Q3 2024
E. Ohman J:Or Asset Management Ab Shares Held: 29.8K ($820K)

Top Sells

Q3 2024
Sg Americas Securities, LLC Shares Held: 9.86K ($271K)
Q3 2024
Allspring Global Investments Holdings, LLC Shares Held: 7.37K ($203K)
Q3 2024
New York State Common Retirement Fund Shares Held: 22.5K ($619K)
Q3 2024
Hennion & Walsh Asset Management, Inc. Shares Held: 64.1K ($1.76M)
Q3 2024
Us Bancorp \De\ Shares Held: 1.68K ($46.1K)

About ARVN

Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer; and ARV-766 an investigational orally bioavailable PROTAC protein degrader for the treatment of men with mCRPC. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut.


Insider Transactions at ARVN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
418K Shares
From 17 Insiders
Grant, award, or other acquisition 410K shares
Exercise of conversion of derivative security 8.25K shares
Sell / Disposition
10.3K Shares
From 4 Insiders
Open market or private sale 10.3K shares

Track Institutional and Insider Activities on ARVN

Follow ARVINAS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARVN shares.

Notify only if

Insider Trading

Get notified when an Arvinas, Inc. insider buys or sells ARVN shares.

Notify only if

News

Receive news related to ARVINAS, INC.

Track Activities on ARVN